RETROSPECTIVE EVALUATION OF THERAPY WITH KETOCONAZOLE IN HORMONE-REFRACTORY PROSTATE CANCER (HRPC)

被引:0
|
作者
Bonetta, Alberto [1 ]
Derelli, Roberto [1 ]
机构
[1] Ist Ospitaleri Cremona, Cremona, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1942 / 1943
页数:2
相关论文
共 50 条
  • [21] Combination therapy in hormone-refractory prostate cancer
    Daniel P. Petrylak
    Current Oncology Reports, 2001, 3 (5) : 453 - 453
  • [22] Gene profiling in transurethral resection samples of patients with hormone-refractory prostate cancer (HRPC).
    Stoss, O.
    Albers, P.
    Werther, M.
    Zielinsky, D.
    Jost, N.
    Rueschoff, J.
    Henkel, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 251S - 251S
  • [23] Polyamine-reduced diet in metastatic hormone-refractory prostate cancer (HRPC) patients
    Cipolla, B
    Guillé, F
    Moulinoux, JP
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 384 - 387
  • [24] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [25] Hormone-refractory prostate cancer
    Alexandre, I.
    Rixe, O.
    ANNALES D UROLOGIE, 2007, 41 (02) : 47 - 55
  • [26] Targeted therapy in hormone-refractory prostate cancer (HPRC)
    Sternberg, C. N.
    ANNALS OF ONCOLOGY, 2007, 18 : 21 - 21
  • [28] Antiandrogen and vaccine therapy for hormone-refractory prostate cancer
    Alexandra King
    Nature Clinical Practice Oncology, 2005, 2 (11): : 541 - 542
  • [29] Antiandrogen and vaccine therapy for hormone-refractory prostate cancer
    Alexandra King
    Nature Clinical Practice Urology, 2005, 2 (11): : 524 - 525
  • [30] Advantages of Second Line Estramustine for Overall Survival of Hormone-Refractory Prostate Cancer (HRPC) Patients
    Naiki, Taku
    Okamura, Takehiko
    Kawai, Noriyasu
    Sakagami, Hiroshi
    Yamada, Yasuyuki
    Fujita, Keiji
    Akita, Hidetoshi
    Hashimoto, Yoshihiro
    Tozawa, Keiichi
    Kohri, Kenjiro
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009, 10 (01) : 71 - 74